Lattice Biologics Ltd V.LBL.H

Primary Symbol: LBLTF

Healthcare Medical Devices

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

GREY:LBLTF - Post by User

Lattice Biologics Ltd

<< Previous

Bullboard Posts

Next >>

Post by MaterialWorldon Feb 21, 2020 6:40am

208 Views

Post# 30716451

Guy is driving LBL forward

with total revenue for year end Sept 30 2018 @ $ 1,155,041
Sept 30 2019 @ $ 2,188,631
projected revenue Sept 30 2020 @ $ 3.1 - 3.5 Million dollars

New research and developement products on board. Great work Guy. LBL heading down the road to being profitable = Game changer GLTA MW

<< Previous

Bullboard Posts

Next >>

Showcase Minerals identifies uranium and rare earth elements in Quebec